These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3677360)

  • 41. Effect of procainamide and N-acetylprocainamide on atrial flutter: studies in vivo and in vitro.
    Wu KM; Hoffman BF
    Circulation; 1987 Dec; 76(6):1397-408. PubMed ID: 2445503
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of procainamide on wave-front dynamics during ventricular fibrillation in open-chest dogs.
    Kwan YY; Fan W; Hough D; Lee JJ; Fishbein MC; Karagueuzian HS; Chen PS
    Circulation; 1998 May; 97(18):1828-36. PubMed ID: 9603538
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Arrhythmogenesis of changes in cellular ionic environments: ischemia-induced increase in intracellular resistance and slow conduction].
    Fujino T; Takahashi N; Ito M
    Rinsho Byori; 1991 Aug; 39(8):793-800. PubMed ID: 1920873
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Electrophysiologic effects of procainamide in subtherapeutic to therapeutic doses on human atrioventricular conduction system.
    Ogunkelu JB; Damato AN; Akhtar M; Reddy CP; Caracta AR; Lau SH
    Am J Cardiol; 1976 Apr; 37(5):724-31. PubMed ID: 773160
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The electrophysiological actions of lidocaine on ischemic ventricular muscle as compared with procainamide.
    Toyama J; Furuta T
    Jpn Circ J; 1983 Jan; 47(1):82-91. PubMed ID: 6827774
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Procainamide-induced slowing of ventricular tachycardia with insights from analysis of resetting response patterns.
    Stamato NJ; Frame LH; Rosenthal ME; Almendral JM; Gottlieb CD; Josephson ME
    Am J Cardiol; 1989 Jun; 63(20):1455-61. PubMed ID: 2729132
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Use-dependent prolongation of ventricular tachycardia cycle length by type I antiarrhythmic drugs in humans.
    Kidwell GA; Greenspon AJ; Greenberg RM; Volosin KJ
    Circulation; 1993 Jan; 87(1):118-25. PubMed ID: 8418998
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of incremental doses of procainamide on ventricular refractoriness, intraventricular conduction, and induction of ventricular tachycardia.
    Morady F; DiCarlo LA; de Buitleir M; Krol RB; Baerman JM; Kou WH
    Circulation; 1986 Dec; 74(6):1355-64. PubMed ID: 2430731
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bradycardia-dependent triggered activity: relevance to drug-induced multiform ventricular tachycardia.
    Brachmann J; Scherlag BJ; Rosenshtraukh LV; Lazzara R
    Circulation; 1983 Oct; 68(4):846-56. PubMed ID: 6616779
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Conventional and sustained-release procainamide: update on pharmacology and clinical use.
    Anderson JL
    Clin Ther; 1985; 7(5):618-40. PubMed ID: 3902240
    [TBL] [Abstract][Full Text] [Related]  

  • 51. T wave changes persisting after ventricular pacing in canine heart are altered by 4-aminopyridine but not by lidocaine. Implications with respect to phenomenon of cardiac 'memory'.
    del Balzo U; Rosen MR
    Circulation; 1992 Apr; 85(4):1464-72. PubMed ID: 1555287
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Iontophoretic transmyocardial drug delivery. A novel approach to antiarrhythmic drug therapy.
    Avitall B; Hare J; Zander G; Bockoff C; Tchou P; Jazayeri M; Akhtar M
    Circulation; 1992 Apr; 85(4):1582-93. PubMed ID: 1555296
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Frequency-dependent effects of amitriptyline on ventricular conduction and cardiac rhythm in dogs.
    Nattel S
    Circulation; 1985 Oct; 72(4):898-906. PubMed ID: 4028383
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Changes in conduction velocity during acute ischemia in ventricular myocardium of the isolated porcine heart.
    Kléber AG; Janse MJ; Wilms-Schopmann FJ; Wilde AA; Coronel R
    Circulation; 1986 Jan; 73(1):189-98. PubMed ID: 3940667
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High [Ca2+]o-induced electrical heterogeneity and extrasystolic activity in isolated canine ventricular epicardium. Phase 2 reentry.
    Di Diego JM; Antzelevitch C
    Circulation; 1994 Apr; 89(4):1839-50. PubMed ID: 7511994
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacological activation of IKr impairs conduction in guinea pig hearts.
    Larsen AP; Olesen SP; Grunnet M; Poelzing S
    J Cardiovasc Electrophysiol; 2010 Aug; 21(8):923-9. PubMed ID: 20163495
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Electrophysiological effects of high cocaine concentrations on intact canine heart. Evidence for modulation by both heart rate and autonomic nervous system.
    Clarkson CW; Chang C; Stolfi A; George WJ; Yamasaki S; Pickoff AS
    Circulation; 1993 Mar; 87(3):950-62. PubMed ID: 8443914
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Selective depression of conduction of premature action potentials in canine Purkinje fibres by class Ib antiarrhythmic drugs: comparison with Ia and Ic drugs.
    Pallandi RT; Campbell TJ
    Cardiovasc Res; 1988 Mar; 22(3):171-8. PubMed ID: 3167941
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Electrophysiologic actions of clofilium and lidocaine in ischemically injured canine epicardium.
    Patterson E; Scherlag BJ; Lazzara R
    J Pharmacol Exp Ther; 1992 Jul; 262(1):375-82. PubMed ID: 1625209
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Electrophysiological effects of ACC-9358, a novel class I antiarrhythmic agent, on isolated canine Purkinje fibers and ventricular muscle.
    Brown BS
    J Pharmacol Exp Ther; 1989 Feb; 248(2):552-8. PubMed ID: 2918472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.